RTI Surgical (RTIX), a surgical implant company, said Friday that it has been selected to become part of a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI) – the twelfth Manufacturing USA institute, headquartered in Manchester, New Hampshire. ARMI brings together a consortium of nearly 100 partner organizations from industry, government, academia and the non-profit sector to develop next-generation manufacturing processes and technologies for cells, tissues and organs.
Under the umbrella of Manufacturing USA, a public-private network that invests in the development of advanced manufacturing technologies, ARMI will work to integrate and organize the fragmented collection of industry practices and domestic capabilities in tissue biofabrication technology in order to better position the US relative to global competition. ARMI will also focus on accelerating regenerative tissue research and creating state-of-the-art manufacturing innovations in biomaterial and cell processing for critical Department of Defense and civilian needs.